Surmodics, Inc. (SRDX)
42.98
+0.15 (0.35%)
Inactive · Last trade price on Nov 18, 2025
Surmodics Revenue
Surmodics had revenue of $29.57M in the quarter ending June 30, 2025, a decrease of -2.55%. This brings the company's revenue in the last twelve months to $120.80M, down -0.02% year-over-year. In the fiscal year ending September 30, 2024, Surmodics had annual revenue of $126.08M, down -4.91%.
Revenue (ttm)
$120.80M
Revenue Growth
-0.02%
P/S Ratio
5.07
Revenue / Employee
$310,542
Employees
389
Market Cap
614.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 126.08M | -6.51M | -4.91% |
| Sep 30, 2023 | 132.58M | 32.63M | 32.65% |
| Sep 30, 2022 | 99.95M | -5.19M | -4.93% |
| Sep 30, 2021 | 105.14M | 10.27M | 10.83% |
| Sep 30, 2020 | 94.86M | -5.21M | -5.21% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSRDX News
- 3 days ago - Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today - Business Wire
- 9 days ago - Federal Judge Clears Path For GTCR's Takeover Of Surmodics After FTC Challenge - Benzinga
- 10 days ago - Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR - Business Wire
- 16 days ago - Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations - Business Wire
- 17 days ago - Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3 - Business Wire
- 3 months ago - Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance - Business Wire
- 3 months ago - Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - Business Wire
- 7 months ago - Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance - Business Wire